[
  {
    "ts": null,
    "headline": "The Bull Case For Gilead Sciences (GILD) Could Change Following European Approval of Twice-Yearly HIV Prevention Injection",
    "summary": "Gilead Sciences announced that the European Commission has granted marketing authorization for Yeytuo (lenacapavir), the first and only twice-yearly injectable HIV-1 pre-exposure prophylaxis, allowing its use for adults and adolescents at increased risk in the European Union, Norway, Iceland, and Liechtenstein. This approval not only marks a regulatory milestone but also underscores lenacapavir's unique positioning as an innovative, long-acting preventive solution endorsed by both the FDA...",
    "url": "https://finnhub.io/api/news?id=e17fa69da5ed31c6edfde2665e4aefa6d7a3d77ab44bae257c85ce16f6f72ba1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756289826,
      "headline": "The Bull Case For Gilead Sciences (GILD) Could Change Following European Approval of Twice-Yearly HIV Prevention Injection",
      "id": 136536623,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences announced that the European Commission has granted marketing authorization for Yeytuo (lenacapavir), the first and only twice-yearly injectable HIV-1 pre-exposure prophylaxis, allowing its use for adults and adolescents at increased risk in the European Union, Norway, Iceland, and Liechtenstein. This approval not only marks a regulatory milestone but also underscores lenacapavir's unique positioning as an innovative, long-acting preventive solution endorsed by both the FDA...",
      "url": "https://finnhub.io/api/news?id=e17fa69da5ed31c6edfde2665e4aefa6d7a3d77ab44bae257c85ce16f6f72ba1"
    }
  },
  {
    "ts": null,
    "headline": "Analyst Says Gilead (GILD) is a ‘Very High Quality’ Cheap Stock – Here’s Why",
    "summary": "We recently published Top 10 Trending Stocks to Watch Ahead of Nvidia Earnings. Gilead Sciences Inc (NASDAQ:GILD) is one of the top trending stocks to watch ahead of Nvidia earnings. Rob Sechan from NewEdge Capital Group said in a recent program on CNBC that he’s buying Gilead Sciences Inc (NASDAQ:GILD) and explained his bullish case […]",
    "url": "https://finnhub.io/api/news?id=11fbec6f5c184a37ab4ddd2845dc14a002b3f6ff1ebd4d1fab2ce7a71af6636b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756277808,
      "headline": "Analyst Says Gilead (GILD) is a ‘Very High Quality’ Cheap Stock – Here’s Why",
      "id": 136536624,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "We recently published Top 10 Trending Stocks to Watch Ahead of Nvidia Earnings. Gilead Sciences Inc (NASDAQ:GILD) is one of the top trending stocks to watch ahead of Nvidia earnings. Rob Sechan from NewEdge Capital Group said in a recent program on CNBC that he’s buying Gilead Sciences Inc (NASDAQ:GILD) and explained his bullish case […]",
      "url": "https://finnhub.io/api/news?id=11fbec6f5c184a37ab4ddd2845dc14a002b3f6ff1ebd4d1fab2ce7a71af6636b"
    }
  }
]